Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.
Computed tomography
Non-small cell lung cancer
Prognostic factors
Solid size
TNM classification
Journal
Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931
Informations de publication
Date de publication:
07 Jun 2019
07 Jun 2019
Historique:
received:
29
01
2019
accepted:
26
05
2019
entrez:
9
6
2019
pubmed:
9
6
2019
medline:
14
8
2019
Statut:
epublish
Résumé
For subsolid non-small cell lung cancers (NSCLCs), solid size (SS), which is the maximal diameter of the solid component, correlates more accurately with tumor prognosis than the total size, which is the maximal diameter of the entire tumor, including ground-glass opacity. We reviewed the propriety of the TNM staging based on the SS for early-stage NSCLCs. We retrospectively reviewed the preoperative radiological reports, clinical records, and pathological reports of NSCLC cases in our hospital between 2010 and 2013, and clinical stage (c-Stage) 0 and I tumors were selected. Disease-free survival (DFS), based on survival analysis, was used to assess the tumor characteristics that predicted the prognosis. A total of 247 NSCLC diagnoses in 231 patients (88 women and 143 men; age, 67 ± 7 years) were included in our cohort. They were classified into solid (n = 131) and subsolid (n = 116) nodules. The DFS curves indicated that prognosis was significantly worse in the following order: c-Stage 0, c-Stage IA, and c-Stage IB tumors (p = 0.016). Patients with solid nodules showed a significantly worse prognosis than patients with subsolid nodules (p < 0.001). A multivariate Cox proportional hazards model showed that the significant predictive factors for DFS were c-Stage (hazard ratio, 1.600; p = 0.020) and solid nodules (hazard ratio, 3.077; p = 0.031). For early-stage NSCLCs, the c-Stage based on the SS in subsolid nodules was useful for predicting postoperative DFS. In addition, whether nodules were solid or subsolid was another independent prognostic factor.
Sections du résumé
BACKGROUND
BACKGROUND
For subsolid non-small cell lung cancers (NSCLCs), solid size (SS), which is the maximal diameter of the solid component, correlates more accurately with tumor prognosis than the total size, which is the maximal diameter of the entire tumor, including ground-glass opacity. We reviewed the propriety of the TNM staging based on the SS for early-stage NSCLCs.
METHODS
METHODS
We retrospectively reviewed the preoperative radiological reports, clinical records, and pathological reports of NSCLC cases in our hospital between 2010 and 2013, and clinical stage (c-Stage) 0 and I tumors were selected. Disease-free survival (DFS), based on survival analysis, was used to assess the tumor characteristics that predicted the prognosis.
RESULTS
RESULTS
A total of 247 NSCLC diagnoses in 231 patients (88 women and 143 men; age, 67 ± 7 years) were included in our cohort. They were classified into solid (n = 131) and subsolid (n = 116) nodules. The DFS curves indicated that prognosis was significantly worse in the following order: c-Stage 0, c-Stage IA, and c-Stage IB tumors (p = 0.016). Patients with solid nodules showed a significantly worse prognosis than patients with subsolid nodules (p < 0.001). A multivariate Cox proportional hazards model showed that the significant predictive factors for DFS were c-Stage (hazard ratio, 1.600; p = 0.020) and solid nodules (hazard ratio, 3.077; p = 0.031).
CONCLUSIONS
CONCLUSIONS
For early-stage NSCLCs, the c-Stage based on the SS in subsolid nodules was useful for predicting postoperative DFS. In addition, whether nodules were solid or subsolid was another independent prognostic factor.
Identifiants
pubmed: 31174613
doi: 10.1186/s40644-019-0219-3
pii: 10.1186/s40644-019-0219-3
pmc: PMC6555755
doi:
Types de publication
Journal Article
Langues
eng
Pagination
33Subventions
Organisme : the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)
ID : 15K09919
Références
Eur J Cardiothorac Surg. 2002 Mar;21(3):514-9
pubmed: 11888773
J Thorac Cardiovasc Surg. 2002 Aug;124(2):285-92
pubmed: 12167788
Chest. 2004 Sep;126(3):725-32
pubmed: 15364748
Lung Cancer. 2007 Nov;58(2):231-7
pubmed: 17673328
J Thorac Oncol. 2013 Dec;8(12):1551-7
pubmed: 24389437
Eur Respir J. 2014 Aug;44(2):483-94
pubmed: 24925923
J Thorac Oncol. 2015 Jul;10(7):990-1003
pubmed: 26134221
Ann Nucl Med. 2015 Dec;29(10):897-905
pubmed: 26342592
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96
pubmed: 26581137
J Thorac Oncol. 2016 Aug;11(8):1204-1223
pubmed: 27107787
Ann Thorac Surg. 2016 Aug;102(2):407-15
pubmed: 27177840
Ann Thorac Surg. 2017 Jul;104(1):313-320
pubmed: 28433219
J Thorac Oncol. 2017 Sep;12(9):1403-1412
pubmed: 28627462
Clin Lung Cancer. 2018 Jan;19(1):e37-e45
pubmed: 28666761
Ann Thorac Cardiovasc Surg. 2017 Dec 20;23(6):291-297
pubmed: 28966230
Clin Lung Cancer. 2018 May;19(3):e303-e312
pubmed: 29307591
Radiology. 2018 Jun;287(3):1030-1040
pubmed: 29533722
Lung Cancer. 2018 Jul;121:91-96
pubmed: 29858033